Connect with us

Politics

Schumer Worries Senate Marijuana Banking Vote Could Undermine Broader Legalization Push

Published

on

Arguably the most closely watched congressional player in the marijuana reform space this session is Senate Majority Leader Chuck Schumer (D-NY). With Democrats now in control of a chamber that for years has been run by GOP members with little to no interest in ending federal prohibition, the pro-legalization senator has found himself in a unique position to lead the charge.

Schumer doesn’t intend to miss that opportunity, as he explained to Marijuana Moment in a phone interview on the eve of the cannabis holiday 4/20. Nor does he want to risk undermining comprehensive reform by passing more modest changes—such as simply protecting banks that service the state-legal industry, as the House did on Monday—before tackling broader legalization.

Together with Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), the majority leader is working on legislation that would federally legalize marijuana—a bill that he’s said will be introduced “shortly” and placed on the floor “soon.”

But Schumer, despite his emphasis on the need to enact cannabis policy change, isn’t giving up specifics on the proposal he’s drafting just yet. What he will say, however, is that it will address social equity. It will prioritize small businesses and people most impacted by the drug war. It will incorporate things like banking protections. And, if lawmakers do their job, it will pass this Congress.

Marijuana Moment spoke to Schumer about a wide range of cannabis issues—from legislative priorities for marijuana reform to President Joe Biden’s ongoing opposition to adult-use legalization. The following interview has been lightly edited for length and clarity.

Marijuana Moment: Minutes ago, the House again approved the Secure and Fair Enforcement (SAFE) Banking Act to give federal protections to banks that work with state-legal marijuana businesses. Should the Senate follow suit, or should comprehensive legalization be addressed first?

Senate Majority Leader Chuck Schumer: I’ve always been of the view that while certainly we have to deal with the banking and financial issues that we should do them together with legalization because the [SAFE Banking Act] brings in some people who might not normally support legalization, and we want to get as broad a coalition as possible. Here in the Senate, it’s our goal—as you know, Senators Booker and Wyden and I are working on comprehensive legalization legislation.

We will hope to include things that deal with banking and finance, although we certainly think that we ought to make sure that the communities that have been most affected by these draconian laws get the benefits here, and we want to make sure that there are reinvestment initiatives and it doesn’t all go to the big shots, that smaller businesses and minority businesses get a chance to be involved once marijuana is legalized. We want to make sure, A) that they go together and B) that this just doesn’t let all the bankers, the big boys, in without taking into account that communities of color have paid the greatest price here and should get some recompense.

MM: To that point, have you had conversations with the Senate sponsors of the SAFE Banking Act about potentially merging their proposal into the legislation you and your colleagues are working on?

CS: Well, no. The first step is for for Booker and Wyden and I to come up with our bill, then we will start having conversations with them. As you know, as the floor leader and the majority leader, I get to determine what gets put on the floor, so if I make a suggestion that it would be good to combine these two pieces of legislation, I think people will pay some attention to that.

MM: Appropriations season will soon be upon us. For the past two years, the House has approved spending bills that include a rider to prevent the Justice Department from using its funds to interfere in any state or territory marijuana programs. The Senate has only signed off on amendments to protect medical cannabis states. Now that you’re in control of the chamber, do you think a temporary policy like that should be pursued while you work on a permanent fix?

CS: Our first goal is not to settle for just partial measures, even though that, obviously if we went to legalization, that would sort of be part of it. We’re first going to try to get as large a piece of legislation as we can.

MM: To what extent have you been coordinating with House leadership on broad legalization? Judiciary Chairman Jerrold Nadler (D-NY) says he plans to soon refile his Marijuana Opportunity, Reinvestment and Expungement (MORE) Act that passed the House last year—have your offices been working together?

CS: We’re talking to the House people. Obviously, a good strong bill needs to pass both houses. The House has been ahead of the Senate here only because Democratic control of the House has been two years longer than Democratic control of the Senate. But we are in definite consultation with our House colleagues.

MM: As you’re well aware, New York Gov. Andrew Cuomo (D) signed legalization into law this month. What will this mean for your home state in the long term, especially as it concerns social equity for communities most impacted by the drug war?

CS: As you know, I weighed in at a crucial time to get as strong a bill that took into account the harms done to communities of color as possible. And I think that had a real effect and New York’s bill, at the end of the day, being a very strong bill, I was very glad to see what they did on expungement. I mean, for a young man or young woman to be arrested with a small amount of marijuana in his or her pocket and then have this serious criminal record because the law was so overdone in terms of penalties.

To treat marijuana the same as cocaine or heroin or anything like that made no sense. And yet so many young people—their lives were basically ruined because they had a severe criminal record because they had a small amount of marijuana in their possession. They never should have had that severe record. So expungement is only fair and only right. They’re mainly state laws so we can’t force expungement, but it’s something that I was very glad New York did and I hope other states will follow that. And we’ll do whatever we can federally as well to encourage it.

MM: Going back to the federal level, we’ve been talking about comprehensive reform. The House only narrowly approved the MORE Act last year, and that was regarded by advocates as fairly broad policy. You need 50 or 60 votes to get the legislation passed depending on how you advance it—are the votes there?

CS: Well, we’re working as hard as we can. We’re first drafting the legislation. We’re talking to people about it. I don’t want to give out what’s in it yet because we’re in the process of doing it and talking to people. But you know, 65 percent of the American people support legalization of marijuana. I was utterly amazed and pleasantly surprised when a conservative state like South Dakota had it as a referendum and it passed so overwhelmingly. Its time has come.

And you know, all the old bugaboos that if marijuana was legalized, crime would go up and marijuana was legalized, drug use would go up. But we’ve had—you know, [U.S. Supreme Court Justice Louis Brandeis] called the states the laboratories of experimentation, and we’ve had those laboratories and they’ve been experimenting. None of these parade of horribles that the opponents of legalization, or even decriminalization, put out came to be true.

I think the American people are realizing not only the harms that have been done to communities of color, but also this this is freedom. And if marijuana is not going to have all these adverse effects—and in fact, we’ll have some positive effects in terms of dealing with legislation, dealing with making up for what has happened to communities of color, it’s a good thing. I think as the Rolling Stones say, “Time is on our side. Yes, it is.”

MM: Senator Booker said in a recent interview that he’s essentially unconcerned about President Biden’s opposition to recreational legalization because, as long as he supports decriminalization federally, he won’t be an obstacle to your pending legislation. Would you agree with that sentiment?

CS: Well, look, I never want to contradict Cory Booker, but I’m gonna keep working on the president to go the whole way. I’ve had some success in persuading him on other things—not related to marijuana, but other issues. I’d like him to understand that the world has changed, the facts have changed and full legalization is the right way to go. Obviously, it’s helpful if he moves in our direction in a significant way. That will be helpful, of course.

MM: Outside of cannabis, I wonder what your thoughts are on more broadly ending the drug war. Oregon voters approved an initiative to decriminalize possession of all currently illicit drugs—is that a policy you support as well?

CS: Certainly, we need much more in treatment. The shortage of treatment is horrible and COVID has exacerbated it. I think we have three times the opioid use than we had pre-COVID. Now we did put about $4 billion into the American rescue plan for more for treatment, but there’s not close to enough. The story I tell is, I knew a man in western New York. His son was an Iraq war veteran, came back with PTSD, became addicted on opioids—and finally his father was trying to convince him to go to treatment and finally, you know, when you hit bottom, the kids said, “Yes, I’ll go.” They went to the local places that provide treatment, and it was 23-week waiting list and the son killed himself in week 22. We need much more focus on treatment. I can’t talk about—I don’t know the specifics of any specific state law, but the focus on rehabilitation treatment is vital.

U.S. House Approves Marijuana Banking Bill For Fourth Time, Setting Up Senate Consideration

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Sacramento-based senior editor. His work has also appeared in High Times, VICE and attn.

Politics

Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC

Published

on

A Washington, D.C.-based psychedelics organization has issued about $50,000 in its first round of grants for various community groups to support efforts to educate and organize people around plant medicine.

The Plant Medicine Coalition (PMC)—founded by the head of the D.C. campaign that got psychedelics decriminalization passed locally in last November’s election—dolled out grants to about a dozen groups as part of its Community Grants Program. Funding for the grants was provided by Dr. Bronner’s, a wellness company that’s been involved in a number of marijuana and psychedelics reform efforts across the country.

This is just one part of PMC’s mission to promote psychedelics reform as the movement continues to spread at the local, state and federal levels.

Arts collectives, mental health organizations and entheogenic education groups are among the new grant recipients.

Melissa Lavasani, PMC co-founder, told Marijuana Moment that the organization is hopeful about the impact of these grants—but it’s also using this opportunity to explore how to most effectively provide funding in the years to come.

“I wanted to do something really impactful that had a quick turnaround,” Lavasani said. “There are a lot of things that our organization is working on right now that are really long term, especially on the federal level.”

“We’re trying to shift a really entrenched culture and government,” she added. “It just takes a lot of grinding—meeting after meeting—and I wanted to do something important with these funds here locally because I do feel like there were a lot of loose ends” after D.C. decriminalized psychedelics.

Overall, the money from PMC will support a diversity of initiatives. There will be workshops on community building within the psychedelics movement, courses on cultivating entheogenic substances, lecture series on scientific developments related to the substances and more.

Here are some quotes from recipients on what they aim to do with the funding: 

The Madison House: “Founded by Master Life Coach H. Alejaibra Badu, The Madison House is a International Spiritual Health & Wellness Movement that stands to heal people from things that bind them mentally and emotionally. Finding freedom from the self-inflicted prison of the mind when it’s over consumed by thought. Freeing yourself from the voice inside your mind that promotes fear, self-doubt, low self-esteem, anxiety, stress, anger, and pain. Freeing yourself from the perceptions of others that leave you in bondage. Freeing your whole self and authentic being. The Madison House belief is that if you are able to be freed from the things that bind you mentally and emotionally, then you can live your life on purpose.”

Delicious Mushroom Growing: “Delicious Mushroom Growing is a project that educates DC residents about how to grow mushrooms from manure and compost substrates – Oyster, Cremini/Portabello/Button/Agaricus, and Shaggy Mane. It’s a way to teach people about how to grow fungi medicine and get themselves on a the path towards healing.”

Plant Medicine Lecture Series: “This lecture series will bring exciting speakers to D.C. to discuss the scientific, medical, and social aspects of psychedelics. The lectures will be offered in public venues, COVID permitting, and webcast as well. The events will also be excellent opportunities to meet other people in D.C. who are interested in psychedelics.”

There are additional recipients who requested not to be publicly listed but are providing “critical education of the community, integration services, as well as providing stewardship of ethical plant medicine community building,” Lavasani said.

Others are involved in “addressing abuse and predatory behaviors in plant medicine circles (a problem that’s become super prevalent lately) to provide a restorative process for healing,” she said.

While based in D.C., PMC is a national organization that hopes to build upon reform efforts that have already been accomplished and bring the issue to Capitol Hill, in part by pushing lawmakers to approve federal funding for research into the therapeutic potential of substances like psilocybin mushrooms and ayahuasca.

The group is also working to ensure the effective implementation of the city-level policy change while supporting other local activists as they push to change laws governing natural or synthetic psychedelics.

Both inside and outside of the nation’s capitol, activists are hard at work pushing for psychedelics reform.

Just last week, for example, lawmakers in a fourth Massachusetts city voted in favor of a resolution urging the decriminalization of certain entheogenic substances and other drugs.

The action comes months after the neighboring Northampton City Council passed a resolution stipulating that no government or police funds should be used to enforce laws criminalizing people for using or possessing entheogenic plants and fungi. Elsewhere in Massachusetts, Somerville and Cambridge have also moved to effectively decriminalize psychedelics.

The local measures also express support for two bills introduced in the Massachusetts state legislature this year. One would remove criminal penalties for possession of all currently illicit drugs and the other would establish a task force to study entheogenic substances with the eventual goal of legalizing and regulating the them.

Separately, Seattle’s City Council approved a resolution earlier this month to decriminalize noncommercial activity around a wide range of psychedelic substances, including the cultivation and sharing of psilocybin mushrooms, ayahuasca, ibogaine and non-peyote-derived mescaline.

In Michigan, the Grand Rapids City Council approved a resolution last month calling for decriminalization of a wide range of psychedelics.

Elsewhere in Michigan, the Ann Arbor City Council has already elected to make enforcement of laws prohibition psychedelics like psilocybin, ayahuasca and DMT among the city’s lowest priorities—and lawmakers recently followed up by declaring September Entheogenic Plants and Fungi Awareness Month.

After Ann Arbor legislators passed that decriminalization resolution last year, the Washtenaw County prosecutor announced that his office will not be pursuing charges over possessing entheogenic plants and fungi, “regardless of the amount at issue.”

A local proposal to decriminalize various psychedelics will also appear on Detroit’s November ballot.

At the same time that local activists are pursuing decriminalization, a pair of Michigan senators introduced a bill last month to legalize the possession, cultivation and delivery of an array of plant- and fungi-derived psychedelics like psilocybin and mescaline.


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

A bill to legalize psychedelics in California advanced through the Senate and two Assembly committees this year before being pulled by the sponsor to buy more time to generate support among lawmakers. The plan is to take up the reform during next year’s second half of the legislative session, and the senator behind the measure says he’s confident it will pass.

California activists were separately cleared to begin collecting signatures for a historic initiative to legalize psilocybin mushrooms in the state. Oakland and Santa Cruz have already enacted psychedelics decriminalization.

The top Democrat in the Florida Senate filed a bill last month that would require the state to research the medical benefits of psychedelics such as psilocybin and MDMA.

Earlier this year, Texas enacted a law directing state officials to study psychedelics’ medical value.

The governor of Connecticut signed a bill in June that includes language requiring the state to carry out a study into the therapeutic potential of psilocybin mushrooms.

Oregon voters passed a pair of initiatives last November to legalize psilocybin therapy and decriminalize possession of all drugs. On the local level, activists in Portland are mounting a push to have local lawmakers pass a resolution decriminalizing the cultivation, gifting and ceremonial use of a wide range of psychedelics.

A New York lawmaker introduced a bill in June that would require the state to establish an institute to similarly research the medical value of psychedelics.

The Maine House of Representatives passed a drug decriminalization bill this year, but it later died in the Senate.

In Oakland, the first city where a city council voted to broadly deprioritize criminalization of entheogenic substances, lawmakers approved a follow-up resolution in December that calls for the policy change to be adopted statewide and for local jurisdictions to be allowed to permit healing ceremonies where people could use psychedelics. Activists in the city are also hoping to expand upon the local decriminalization ordinance by creating a community-based model through which people could legally purchase entheogenic substances from local producers.

Meanwhile, Denver activists who successfully led the 2019 campaign to make the city the first in the U.S. to decriminalize psilocybin possession have set their eyes on broader reform, with plans in the works to end the criminalization of noncommercial gifting and communal use of the psychedelic.

In a setback for advocates, the U.S. House of Representatives recently voted against a proposal from Rep. Alexandria Ocasio-Cortez (D-NY) that would have removed a spending bill rider that advocates say has restricted federal funds for research into Schedule I drugs, including psychedelics such as psilocybin, MDMA and ibogaine. However, it picked up considerably more votes this round than when the congresswoman first introduced it in 2019.

Report provisions of separate, House-passed spending legislation also touch on the need to expand cannabis and psychedelics research. The panel urged NIDA to support expanded marijuana studies, for example. It further says that federal health agencies should pursue research into the therapeutic potential of psychedelics for military veterans suffering from a host of mental health conditions.

There was an attempt by a Republican congressman to attach language into a defense spending bill that would promote research into psychedelics therapy for active duty military members, but it was not made in order in the House Rules Committee last month.

NIDA also recently announced it’s funding a study into whether psilocybin can help people quit smoking cigarettes.

An official with the U.S. Department of Veterans Affairs also said at a recent congressional hearing that the agency is “very closely” following research into the potential therapeutic benefits of psychedelics like MDMA for military veterans.

For what it’s worth, Rep. Earl Blumenauer (D-OR), a longstanding champion of marijuana reform in Congress, said this month that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.”

In May, lawmakers in Congress filed the first-ever legislation to federally decriminalize possession of illicit substances.

Top Federal Drug Agency Tells Congress About Marijuana Research Barriers Caused By Restrictive Scheduling

Photo elements courtesy of carlosemmaskype and Apollo.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Feds Must Legalize Marijuana, Top Nevada Lawmaker Says (Op-Ed)

Published

on

“In Nevada, we’ve shown that it is possible to create an equitable and business friendly framework that benefits both cannabis business owners and consumers. With federal action, we can take this work to the next level.”

By Rep. Steve Yeager for Nevada Current

With gridlock at the federal level, states have truly become the laboratories of democracy—often leading on legislative policy when Congress is unable. When it comes to cannabis, these laboratories of democracy operate at breakneck speed, with 18 U.S. states legalizing it for both medical and adult “recreational” use and at least some legal use in 37 states and the District of Columbia. In a nation where even a small amount of the substance could and often did (and sometimes still does) lead to serious legal consequences, more than 100 million Americans now live in states with legalized, adult-use cannabis markets.

Nevada, of course, has been a trailblazer in legalizing cannabis and as a result, has reaped significant economic and social benefits. When the Legislature established the Cannabis Compliance Board in 2019 with a strong bipartisan majority, Nevada solidified its place as the gold standard for a well-regulated cannabis industry.

In 2021, the Legislature once again demonstrated its ability to create a more equitable and inclusive cannabis industry, securing a bipartisan 2/3 vote in each legislative chamber to pass a bill establishing cannabis consumption lounges. The lounges, set to open in 2022, will bring new jobs and enhanced tax revenue that will allow Nevada to invest more in K-12 education. In addition, Nevada’s tens of millions of tourists will finally have a place to legally consume cannabis. It is clear that Las Vegas is quickly becoming a global cannabis destination.

But despite these immense possibilities, state legalization—without change in federal law—still presents serious challenges. For instance, the lack of contemporary cannabis legislation on the federal level has made any form of traditional banking for the industry next to impossible. Cannabis business owners cannot take advantage of favorable tax provisions that help other businesses keep more of the money they make, often leading to additional investment. Even if cannabis is legal in a particular state, carrying that cannabis on to federal property or on to an airplane opens a person to arrest and prosecution by federal authorities.

Furthermore, federal employees or state employees paid through federal funding cannot partake in cannabis, medical or otherwise. Nevadans who live in federally subsidized housing cannot consume in the comfort of their homes, a prohibition that undoubtedly disproportionately impacts vulnerable communities. And business owners in the industry can never feel completely comfortable because the federal government could choose to use its police power to crack down on state level cannabis businesses.

With polls showing that two-thirds of Americans support legalization of cannabis, it is time for the federal government to legalize it. Such action will pave the way for states that have been hesitant to step out on this issue and will eliminate the current conflicts between federal and state law. Federal legalization will enable more in-depth study of cannabis by both state and federal agencies to develop a scientific standard of impairment for driving and will enable the federal government to help states with efforts to curb youth cannabis use.

Nevada has also led the way in pardoning and sealing criminal records for those convicted of low-level cannabis crimes. Those with federal cannabis convictions have no similar remedy, often preventing them from entering the job market at a time when employees have never been in higher demand. Federal cannabis legalization would open the door to cleaning the slate for criminal convictions stemming from conduct the majority of Americans now agree should not have been illegal in the first place. For both moral and economic reasons, erasing records of low level cannabis convictions is simply the right thing to do. For that to happen, cannabis must be legalized on the federal level.

In Nevada, we’ve shown that it is possible to create an equitable and business friendly framework that benefits both cannabis business owners and consumers. With federal action, we can take this work to the next level.

Steve Yeager is a Democratic state assemblyman representing District 9 in Clark County, and speaker pro tempore of the Nevada State Assembly.

This op-ed was first published by Nevada Current.

Top Federal Drug Agency Tells Congress About Marijuana Research Barriers Caused By Restrictive Scheduling

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Texas Judge Upholds Delta-8 THC Ban In Initial Ruling, But The Fight Isn’t Over

Published

on

A Texas judge has ruled that the state’s ban on hemp products containing more than 0.3 percent delta-8 THC can remain in effect as a legal challenge moves through the process.

The cannabis company Hometown Hero filed a suit against the Texas Department of State Health Services (DSHS) last week, arguing that it improperly revised its hemp policy this month to specifically prohibit products with more than trace amounts of forms of THC other than delta-9, the most commonly known psychoactive compound in cannabis.

In a ruling dated Friday and announced on Monday, the court decided against the plaintiffs’ request to have a temporary restraining order imposed on the state. Subsequently, the hemp business said it will halt sales of certain products as it prepares for a November 5 hearing on a more consequential temporary injunction against the state.

These are just the first steps in yet another legal battle over hemp in the state following the plant’s legalization.

Delta-8 THC has surged in popularity, particularly in states with more restrictive marijuana laws. It produces intoxicating effects similar to delta-9 THC, but it can be synthetically produced by converting CBD derived from hemp. The novelty of delta-8 products has left legal loopholes, which is likely why DSHS moved to broadly prohibit products with more than 0.3 percent of any type of THC.

DSHS appears to have responded to this increased market demand and questions from hemp businesses by updating its policy with the broader interpretation of THC. Here’s what the department’s site now says:

“Texas Health and Safety Code Chapter 443 (HSC 443), established by House Bill 1325 (86th Legislature), allows Consumable Hemp Products in Texas that do not exceed 0.3% Delta-9 tetrahydrocannabinol (THC). All other forms of THC, including Delta-8 in any concentration and Delta-9 exceeding 0.3%, are considered Schedule I controlled substances.”

Hometown Hero had hoped to get a temporary restraining order against DSHS to prevent it from taking action against hemp businesses that sell delta-8 THC, but now it must wait to see what comes out of next month’s follow-up hearing.

“The DSHS stance flips the hemp definition on its head,” an attorney for the plaintiffs said in court on Friday, according to Texas Cannabis Collective.

The department, for its part, says it has not made any policy change and that delta-8 THC has been statutorily classified the same as delta-9 since hemp was legalized in 2019. A spokesperson said it simply “posted the clarification below on our website in response to recent requests from hemp growers who said that there was confusion in the industry about what was allowed in consumable hemp products.”

Activists have criticized DSHS for making hemp policy decisions without affording the public a real chance to participate.

“We expect the Department of State Health Services to always operate with full transparency,” Heather Fazio, director of Texans for Responsible Marijuana Policy, told Marijuana Moment. “It has been made abundantly clear that, by posting meeting notices in obscure locations, DSHS denied the public an opportunity to weigh in on proposed changes to the Controlled Substances Act.”

At the federal level, delta-8 THC has also captured the attention of agencies like the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention. Regulators at those departments recently issued warnings about products containing the cannabinoid, saying they’ve seen a significant uptick in reported adverse health effects.

FDA also announced a plan this month to us “novel” data sources like Reddit to gain a better understanding of public health issues surrounding use of delta-8 THC and other cannabinoids such as CBD.

Back in Texas, the hemp industry has become familiarized with the court system as businesses have navigated the new law.

In the same district court where this new delta-8 THC lawsuit has been filed, a judge ruled in August that Texas’s ban on the production and sale of smokable hemp products is unconstitutional.

Judge Lora Livingston ruled in favor of plaintiffs—a group of hemp businesses who sued the DSHS over a ban on the manufacturing and selling of smokable cannabis products it imposed after the crop was legalized.

An appeals court had previously modified a prior injunction and determined that regulators couldn’t enforce a ban on the sales component of the smokable hemp market. But following the August ruling, there’s a permanent injunction that bars the state from prohibiting the full range of hemp activity.

Meanwhile, Texas activists are working to enact local reforms on marijuana.

Advocates in San Marcos, Texas recently launched a campaign to put marijuana decriminalization on the local ballot in 2022.

Just to the north of San Marcos, a separate campaign attempted to put cannabis decriminalization on Austin’s ballot this November, but activists have since shifted their strategy toward putting the measure in front of voters on the May 2022 ballot. They will also target additional cities next November.

There is no statewide, citizen-led initiative process that would enable advocates to put an issue like decriminalization or legalization on the Texas ballot. But at the local level, there are limited cases where activists can leverage home rule laws that allow for policy changes.

A strong majority of Texans back even broader reform, according to recent polling. Sixty percent of voters in the state support making cannabis legal “for any use,” signaling that local initiatives for more modest proposals like decriminalization will likely prevail where they qualify for local ballots.

This year’s legislative session in Texas saw numerous drug policy proposals advance, with bills to expand the state’s medical cannabis program and require a study into the therapeutic potential of certain psychedelics for military veterans having been enacted.

Advocates remain disappointed, however, that lawmakers were unable to pass more expansive cannabis bills—including a decriminalization proposal that cleared the House but saw no action in the Senate.

The House approved a cannabis decriminalization bill in 2019, but it did not advance in the Senate that session.

Top Federal Drug Agency Tells Congress About Marijuana Research Barriers Caused By Restrictive Scheduling

Photo courtesy of Brendan Cleak.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment